Clinical-Stage Platforms
Part of Biotech - Drug Development
 TMO | Thermo Fisher Scientific, Inc. | $186.3b | $530.38 | -2.0% | 1.1M |
 A | Agilent Technologies Inc. | $37.5b | $132.06 | -3.4% | 1.9M |
 WAT | Waters Corp | $36.8b | $368.86 | -2.4% | 470.7K |
 IQV | IQVIA Holdings Inc. | $32.2b | $204.77 | -2.0% | 1.1M |
 WST | West Pharmaceutical Services, Inc. | $25.4b | $368.00 | -1.2% | 531.2K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $24.9b | $58.31 | -0.6% | 2.2M |
 ASND | Ascendis Pharma A/S Ordinary Share | $17.5b | $261.11 | +0.6% | 596.3K |
 MEDP | Medpace Holdings, Inc. Common Stock | $15.1b | $534.30 | -0.1% | 195.8K |
 ICLR | Icon Plc | $13.3b | $170.09 | -0.0% | 520.5K |
 RVTY | Revvity, Inc. | $12.4b | $110.13 | -1.4% | 1.0M |
 TECH | Bio-Techne Corp. | $11.0b | $71.70 | +0.5% | 2.5M |
 CRL | Charles River Laboratories International, Inc. | $10.9b | $224.34 | -2.1% | 572.0K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $9.4b | $115.83 | +1.5% | 623.8K |
 HALO | Halozyme Therapeutics, Inc. | $9.3b | $77.80 | +0.3% | 1.1M |
 BRKR | Bruker Corporation | $9.2b | $58.21 | -1.7% | 1.3M |
 QGEN | QIAGEN N.V. | $8.1b | $41.14 | -0.9% | 1.9M |
 BIO.B | Bio-Rad Laboratories, Inc. Class B | $7.9b | $308.70 | 0.0% | 7 |
 RGEN | Repligen Corp | $7.7b | $147.19 | -0.9% | 680.0K |
 AVTR | Avantor, Inc. | $6.8b | $11.07 | -1.7% | 8.8M |
 TWST | Twist Bioscience Corporation Common Stock | $6.4b | $93.97 | +2.9% | 1.0M |
 LGND | Ligand Pharmaceuticals Inc. | $6.3b | $303.26 | +2.4% | 246.7K |
 CGON | CG Oncology, Inc. Common stock | $6.3b | $71.87 | +3.3% | 781.0K |
 MANE | Veradermics, Incorporated | $5.1b | $112.58 | +6.7% | 904.2K |
 CELC | Celcuity Inc. Common Stock | $5.1b | $89.25 | +0.2% | 1.2M |
 RLAY | Relay Therapeutics, Inc. Common Stock | $4.1b | $19.89 | +2.8% | 1.8M |
 OGN | Organon & Co. | $3.6b | $13.47 | +0.2% | 1.1M |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $2.9b | $13.32 | +12.1% | 10.8M |
 TRVI | Trevi Therapeutics, Inc. Common Stock | $2.6b | $19.23 | +9.9% | 7.8M |
 NRIX | Nurix Therapeutics, Inc. Common stock | $2.5b | $23.13 | +0.2% | 643.3K |
 KOD | Kodiak Sciences Inc Common Stock | $2.4b | $42.67 | +3.3% | 399.7K |
 ABCL | AbCellera Biologics Inc. Common Shares | $2.4b | $6.48 | +5.0% | 4.1M |
 DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.52 | -0.0% | 3.0M |
 GENB | Generate Biomedicines, Inc. Common Stock | $2.2b | $13.85 | -0.9% | 297.7K |
 GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $2.0b | $25.00 | +6.0% | 1.1M |
 ABSI | Absci Corporation Common Stock | $2.0b | $8.28 | +0.7% | 3.4M |
 BCAX | Bicara Therapeutics Inc. Common Stock | $2.0b | $27.93 | +0.5% | 385.9K |
 RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $1.9b | $2.94 | -2.6% | 18.7M |
 ZYME | Zymeworks Inc. | $1.9b | $24.25 | 0.0% | 350.4K |
 TYRA | Tyra Biosciences, Inc. Common Stock | $1.9b | $31.91 | +1.6% | 462.0K |
 FTRE | Fortrea Holdings Inc. Common Stock | $1.6b | $17.77 | -0.8% | 657.1K |
 HROW | Harrow, Inc. Common Stock | $1.6b | $46.65 | +4.0% | 728.5K |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.4b | $88.00 | -2.2% | 222.7K |
 ALVO | Alvotech Ordinary Shares | $1.2b | $3.46 | +2.4% | 203.0K |
 SDGR | Schrodinger, Inc. Common Stock | $1.2b | $15.30 | -1.7% | 778.2K |
 OPK | Opko Health Inc. | $1.1b | $1.20 | 0.0% | 1.5M |
 CERT | Certara, Inc. Common Stock | $1.0b | $6.93 | -5.1% | 1.7M |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.0b | $25.61 | -0.0% | 295.3K |
 VOR | Vor Biopharma Inc. Common Stock | $1.0b | $18.17 | +4.3% | 868.0K |
 SANA | Sana Biotechnology, Inc. Common Stock | $1.0b | $3.15 | -1.1% | 2.3M |
 MRVI | Maravai LifeSciences Holdings, Inc. Class A Common Stock | $0.9b | $7.20 | +2.3% | 2.6M |